INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

20,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1,288
14 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

Page 331 of 524
← PrevNext →
23
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL
$9,340
100 sh
Apr 8, 2026
Apr 10, 2026
traded Apr 8, 2026
+2d
SEC Form 4

Evidence

22
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale
SELL$55K
7,734 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

22
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$49K
14.5K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

22
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
1,683 sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC Form 4

Evidence

19
RS
Robins Harlan SChief Scientific Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$149K
10.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

18
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.02M
1,756 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

18
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.13M
1,956 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

17
MJ
McCallion Kevin J.SVP, Products and Production
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$131K
18.6K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
3,310 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,424
1,988 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$1,978
162 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$14K
2,861 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$14K
2,800 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$739K
8,224 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
1,681 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
PD
Papadopoulos DidierPresident of Aircraft OEM
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$2,295
271 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$14K
2,800 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
3,000 sh
Apr 10, 2026Apr 10, 2026
traded Apr 10, 2026
+0dSEC Form 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,176
1,936 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$13K
2,786 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,244
1,950 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$6,801
1,403 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$1.25M
8,100 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,239
1,950 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$283K
12.5K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$19K
3,824 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$14K
2,800 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,152
1,931 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

15
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$915K
1,586 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

15
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$710K
1,224 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

15
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$934K
1,617 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

14
SA
Schlachet AmirDirector, CEO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$129K
4,001 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

14
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$129K
4,007 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$463K
3,200 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$106K
15.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$103K
332 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$659K
1,139 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$322K
560 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

11
BL
Brooks Jayme L.Chief Financial Officer
LMBLimbach Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$287K
3,366 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence